These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23470954)

  • 1. [Malassezia and its presumed association with skin diseases in dogs].
    Nagata M
    Med Mycol J; 2013; 54(1):45-7. PubMed ID: 23470954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
    Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between phospholipase production by Malassezia pachydermatis and skin lesions.
    Cafarchia C; Otranto D
    J Clin Microbiol; 2004 Oct; 42(10):4868-9. PubMed ID: 15472366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'spore of Malassez' as a canine skin pathogen: lessons from history?
    Bond R
    Vet Dermatol; 2014 Aug; 25(4):292-3. PubMed ID: 25124175
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two shampoos for treatment of Malassezia pachydermatis-associated seborrhoeic dermatitis in basset hounds.
    Bond R; Rose JF; Ellis JW; Lloyd DH
    J Small Anim Pract; 1995 Mar; 36(3):99-104. PubMed ID: 7783442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.
    Yurayart C; Nuchnoul N; Moolkum P; Jirasuksiri S; Niyomtham W; Chindamporn A; Kajiwara S; Prapasarakul N
    Med Mycol; 2013 Oct; 51(7):721-30. PubMed ID: 23547880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study to evaluate two miconazole conditioners for the treatment of Malassezia dermatitis in dogs.
    Marsella R; Nicklin CE; Nerbonne J
    Vet Ther; 2000; 1(3):141-9. PubMed ID: 19757576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological and clinical aspects of the diseases caused by Malassezia species.
    Dorogi J
    Acta Microbiol Immunol Hung; 2002; 49(2-3):363-9. PubMed ID: 12109170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malassezia pachydermatis carriage in dog owners.
    Morris DO
    Emerg Infect Dis; 2005 Jan; 11(1):83-8. PubMed ID: 15705327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with and prevalence of high Malassezia pachydermatis numbers on dog skin.
    Plant JD; Rosenkrantz WS; Griffin CE
    J Am Vet Med Assoc; 1992 Sep; 201(6):879-82. PubMed ID: 1399796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine
    Bajwa J
    Can Vet J; 2017 Oct; 58(10):1119-1121. PubMed ID: 28966366
    [No Abstract]   [Full Text] [Related]  

  • 12. The biology of Malassezia organisms and their ability to induce immune responses and skin disease.
    Chen TA; Hill PB
    Vet Dermatol; 2005 Feb; 16(1):4-26. PubMed ID: 15725101
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of topical therapy of Malassezia pachydermatis-associated seborrhoeic dermatitis on oral carriage of M pachydermatis.
    Bond R; Lloyd DH
    Vet Rec; 1998 Jun; 142(26):725-6. PubMed ID: 9682432
    [No Abstract]   [Full Text] [Related]  

  • 14. Superficial veterinary mycoses.
    Bond R
    Clin Dermatol; 2010 Mar; 28(2):226-36. PubMed ID: 20347667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
    Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds.
    Guillot J; Bensignor E; Jankowski F; Seewald W; Chermette R; Steffan J
    Vet Dermatol; 2003 Jun; 14(3):153-7. PubMed ID: 12791049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malassezia related diseases].
    Sei Y
    Med Mycol J; 2012; 53(2):97-102. PubMed ID: 22728591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of Malassezia yeasts.
    Cafarchia C; Otranto D
    Parassitologia; 2008 Jun; 50(1-2):65-7. PubMed ID: 18693560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability and phospholipase production of Malassezia pachydermatis isolated from dogs with diverse grades of skin lesions.
    Machado ML; Cafarchia C; Otranto D; Ferreira RR; Bianchi SP; Latrofa MS; Parisi A; Ferreiro L
    Med Mycol; 2010 Sep; 48(6):889-92. PubMed ID: 20105099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noninferiority clinical trial comparing fluconazole and ketoconazole in combination with cephalexin for the treatment of dogs with Malassezia dermatitis.
    Sickafoose L; Hosgood G; Snook T; Westermeyer R; Merchant S
    Vet Ther; 2010; 11(2):E1-13. PubMed ID: 20957617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.